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ABSTRACT
Current practices to maintain human pluripotent stem
cells (hPSCs), which include induced pluripotent stem cells
and embryonic stem cells, in an undifferentiated state typi-
cally depend on the support of feeder cells such as mouse
embryonic fibroblasts (MEFs) or an extracellular matrix
such as Matrigel. Culture conditions that depend on these
undefined support systems limit our ability to interpret
mechanistic studies aimed at resolving how hPSCs interact
with their extracellular environment to remain in a unique
undifferentiated state and to make fate-changing lineage
decisions. Likewise, the xenogeneic components of MEFs
and Matrigel ultimately hinder our ability to use pluripo-
tent stem cells to treat debilitating human diseases. Many
of these obstacles have been overcome by the development
of synthetic coatings and bioreactors that support hPSC
expansion and self-renewal within defined culture condi-
tions that are free from xenogeneic contamination. The
establishment of defined culture conditions and synthetic
matrices will facilitate studies to more precisely probe the
molecular basis of pluripotent stem cell self-renewal and
differentiation. When combined with three-dimensional
cultures in bioreactors, these systems will also enable
large-scale expansion for future clinical applications. STEM
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INTRODUCTION
Like other stem cells, human pluripotent stem cells (hPSC)
have the capacity for self-renewal and differentiation into spe-
cialized cell types. However, pluripotent cells are unique in
their ability to self-renew indefinitely. They also feature the
capacity to differentiate into all the approximately 200 speci-
alized cell types of the body. These two fundamental charac-
teristics make hPSCs a potential source of cells for regenera-
tive medicine, drug discovery, disease modeling, and studies
aimed to better understand human development. Human em-
bryonic stem cells (hESCs) are isolated from the inner cell
mass of the blastocyst [1], while human-induced pluripotent
stem cells (hiPSCs) are derived by the overexpression of key
transcription factors in somatic cells [2, 3]. Both of these
PSCs share the expression of transcription factors (Oct4,
Sox2, and Nanog), cell surface markers such as the stage-spe-
cific embryonic antigens (SSEA-3 and SSEA-4) the keratan
sulfate-related antigens (TRA-1-60 and TRA-1-81), high telo-
merase, and alkaline phosphatase activity as well as the
capacity to grow indefinitely in vitro when cultured under per-
missive conditions.
To maximize the potential of PSCs in regenerative medi-
cine and for future transplantation studies, in vitro derivation
and continuous culture conditions need to be performed using
good manufacturing practices. This objective was clear from
the first derivation and prolonged culture of hESCs [1] and
subsequently a rapid evolution in derivation and culture meth-
ods has been realized. The early culture conditions for hESCs
were determined by effectively following the methods devel-
oped for mouse ESCs [4]. These early methods included co-
culture of hESCs with irradiated mouse embryonic fibroblasts
(MEF) in an enriched culture medium containing fetal bovine
serum. It soon became evident, however, that hESCs and
mouse ESCs requirements for self-renewal are distinct. The
principle difference between the two species is that the
growth of undifferentiated hESCs cannot be maintained in
feeder-free conditions in the presence of leukemia inhibitory
factor, as it is possible for mouse ESCs [5].
Since the initial description of the successful derivation
and culture of hESCs [1], several hundred lines of human
ESCs and iPSCs have been derived and investigation of their
biologic characteristics has contributed to the identification of
key molecular pathways and transcription factors that are
involved in the self-renewal and lineage differentiation of
PSCs. This in turn has been translated into knowledge to opti-
mize the culture conditions of PSCs. In this concise review,
we summarize the evolution in hPSC culture and place an
emphasis on the use of synthetic coatings as substrates to
support the unlimited proliferation of hPSCs in vitro (Fig. 1;
Table 1).
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RISKS ASSOCIATED WITH FEEDER CELLS AND
XENOGENEIC COMPONENTS AND THEIR
IMPEDIMENT TO MECHANISTIC STUDIES
Feeder cells such as MEFs support the self-renewal of hPSCs
by the secretion of essential growth factors, cytokines, and
extracellular matrices (ECM) such as transforming growth fac-
tor b, activin A, laminin-511, and vitronectin [25]. However,
inconsistencies in expression and secretion of these factors by
different feeder cells [25, 26 ] make it difficult to determine
which components are indispensible for the support of hPSCs
in an undifferentiated state. Moreover, the c-irradiation of
feeder cells not only impedes their proliferation but also indu-
ces apoptosis and subsequently alters the secretion of soluble
factors and deposition of an ECM. All these factors may nega-
tively affect the self-renewal and consistent culture of hPSCs
[27]. Thus, the dynamic and undefined microenvironment that
feeder cells create limits our ability to interpret mechanistic
studies designed to understand the biology of hPSCs.
Feeder cells and their products can also be a source of
pathogens for hPSCs. For example, in the coculture of hESCs
and MEFs with animal-derived serum replacements, the detec-
tion of an immunogenic sialic acid (Neu5Gc) has been
reported [28]. This is of particular concern because the pres-
ence of non-human sialic acid may induce an immune
response upon transplantation of hPSC derivatives. Xenoge-
neic feeder cells and serum are also a common source of
mycoplasma contamination. Because mycoplasmas compete
with host cells for essential nutrients, mycoplasma contamina-
tion of cultured cells may compromise diverse aspects of cell
physiology such as cell growth, phenotype, karyotype, and
induction of cytokine expression. These infections often go
undetected and consequently could alter the interpretation of
key experimental observations (see [29] for literature review).
In an effort to prevent xenogeneic contaminations, human
feeder cells and serum have been proposed for the culture of
hPSCs (see [30] for literature review). However, the risk of
contamination by viral and nonviral infectious agents also
exists when using human feeder cells (see [31] for literature
review).
FEEDER-FREE CULTURE SYSTEMS AND
THEIR BENEFITS IN UNDERSTANDING THE
BIOLOGY OF hPSCs
One of the first examples of alternatives to feeder-dependent
PSC cultures was the demonstration of long-term culture of
hESCs on tissue culture plates coated with Matrigel in combi-
nation with MEF-conditioned medium [6]. Matrigel is com-
posed mainly of laminin, collagen IV, heparin sulfate proteo-
glycans, entactin, and growth factors [32]. However, Matrigel
is derived from Engelbreth-Holm-Swarm mouse sarcomas
[32], exhibits lot-to-lot variability, and can introduce
unwanted xenogeneic contaminants. Therefore, Matrigel is not
an ideal substrate for feeder-free culture of hPSCs if the pri-
mary objective is to culture these cells for eventual human
therapies. Nevertheless, Matrigel remains one of the most
commonly used substrates and has served as an important
starting point to define the requirements for hPSC growth and
differentiation.
The individual components of Matrigel exhibit varying
degrees of support for PSCs. Laminin-coated surfaces support
the growth of hESCs [6]. In contrast, when cultured on fibro-
nectin and collagen IV, the self-renewal of hESCs is compro-
mised [6]. It has also been reported that the specific laminin
isoforms -111, -332, and -511 support the adhesion and prolif-
eration of undifferentiated hESCs, while isoforms -211 and
411 do not [13]. In addition, it has been shown that support-
ive feeder cells [25] and hESCs [6, 13 ] produce laminin iso-
forms -511/-521 and express the integrin a6b1 receptor, the
primary receptor for these laminin isoforms [33]. The laminin
isoform -511 is abundant in the embryonic basement mem-
brane [34] and is also supportive of mouse ESC cultures [35].
Therefore, these findings suggest that mechanisms responsible
for self-renewal of hPSCs in vitro may be conserved between
species.
Because integrins are the principal cell surface receptors
that mediate cell-ECM interactions, it is likely that the identifi-
cation of integrins in hPSCs signal the use of other supporting
ECM proteins for self-renewal of these pluripotent stem cells.
Following this hypothesis, vitronectin has been shown to
Figure 1. Evolution of human pluripotent stem cell (hPSC) culture. The in vitro culture of hPSCs has evolved to achieve xenogeneic-free and
defined conditions. The illustration depicts this progression (left to right) from coculture with feeder cells and serum-containing medium, to
feeder-independent cultures in chemical-defined medium. Feeder-free conditions have progressed from the use of complex combinations of ECM
proteins like Matrigel as a substrate, to individual ECM molecules such as laminin-511, vitronectin, and fibronectin. The third generation sub-
strates for hPSC culture are defined by the use of synthetic components in combination with biologic motifs such as RGD peptides. Advanced
materials now provide a fully synthetic substrate that support clonal growth, derivation, and long-term culture of genomically stable hPSCs. The
gradient transition from dark to light red color (left to right) indicates the complexity of the culture medium, from undefined to defined
components. hPSCs are illustrated as the rectangular cells with a prominent red nuclei, while fibroblasts are shown as elongated cells with blue
nuclei. Abbreviation: ECM, extracellular matrix.
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support hESC self-renewal via integrin aVb5 [14]. Similarly,
E-cadherin, which mediates cell-cell interactions and has been
involved in hESC colony formation [36] and self-renewal [37],
has been used as a substrate for long-term culture of hPSCs
[16]. The use of recombinant human (rh) laminin -511 [13], rh
vitronectin [14], and rh E-cadherin [16] represents significant
milestones in the culture of hPSCs because they were the first
examples of defined and xenogeneic-free substrates.
FROM NONDEFINED TO DEFINED CONDITIONS:
CULTURE MEDIUM AND SUPPORTIVE
SUBSTRATES
While this review places an emphasis on the cell culture sub-
strates, one must acknowledge that the culture medium plays
an essential role in achieving a defined culture system for
hPSCs. As mentioned above, the secretion of soluble factors by
feeder cells influences the fate of PSCs in self-renewal and dif-
ferentiation. Consequently, conditioned medium from feeder
cells has been commonly used to culture hPSCs in feeder-free
conditions. However, due to its undefined characteristics, vari-
ability, and the risks associated with contaminants, more rigor-
ous practices include the use of chemically defined culture me-
dium. While several culture media formulations [7–11, 15]
have been developed to support the culture of hPSCs in feeder-
free conditions, it should be noted that all these media
formulations were developed using Matrigel as a substrate.
Additionally, some media formulations have also been shown
to be effective when used with individual ECM proteins like
fibronectin [8], laminin [7], or vitronectin [15] and with
synthetic substrates [17–22] that support undifferentiated hPSC
proliferation.
The combination of chemically defined medium and xeno-
geneic-free biological substrates represents significant pro-
gress in the generation of clinically compliant culture systems
for hPSCs. Nevertheless, for large-scale expansion of hPSCs
in chemically defined and clinically compliant conditions, bio-
logical substrates have drawbacks that must be overcome.
These barriers include factors such as batch-to-batch variabili-
ty, limited scalability, difficultly in isolation, expense to man-
ufacture, and the need to ensure pathogen-free conditions. As
important alternatives, synthetic substrates that support the
proliferation of undifferentiated hPSCs have been developed
[17–20, 22]. These synthetic environments will likely prove
to be superior because they exhibit little batch-to-batch varia-
tion, are defined, are reproducible, are stable, are amenable to
standard sterilization techniques, and can be readily tuned to
meet the culture requirements for different hPSC lines.
Due to the anchorage-dependent nature of hPSCs, synthetic
substrates must allow cell adhesion, spreading, self-renewal,
and subsequent colony formation of undifferentiated hPSCs.
Furthermore, hPSCs cultured on synthetic substrates must
retain the unique nature of pluripotency and must not develop
chromosomal and genomic abnormalities. In addition, synthetic
coatings should demonstrate efficacy in the long-term culture
of multiple stem cell lines/types, be compatible with common
biomedical sterilization methods, be cost-effective and have
the potential to be scaled-up for commercial purposes.
To create defined synthetic substrates that allow the long-
term propagation of hPSCs, several materials and material
combinations have been developed and tested. For example,
peptide or protein-based systems, polymers and polymers in
conjunction with biomolecules have been developed. Many of
these systems exploit biologic moieties to achieve appropriate
culture conditions. The success of this approach was realized
when the heparin-binding peptide GKKQRFRHRNRKG was
conjugated to an alkanethiol self-assembled monolayer for the
long-term culture of hESCs [18]. Similarly, arrays of laminin-
derived peptides have also been shown to support hESCs [12].
Among the polymer-based substrates is the zwitterionic
hydrogel, poly2-(methacryloyloxy)ethyl dimethyl-(3-sulfopro-
pyl)ammonium hydroxide (PMEDSAH), that has been devel-
oped using a surface initiated graft polymerization technique.
The surface coatings composed of PMEDSAH are fully syn-
thetic and are extremely effective in sustaining the long-term
expansion of hESCs and hiPSCs [22–24]. Other polymers
coatings for hPSCs include polymer Hit9 [19] and the amino-
propylmethacrylamide (APMAAm) [21], a methacrylamide
containing polymer. Both of these polymers are fabricated by
photopolymerization. Poly(methyl vinyl ether-alt-maleic anhy-
dride) (PMVE-alt-MA), an anhydride containing polymer
coating generated by radical polymerization [17], is another
synthetic material that supports hPSCs. Other research groups
have taken a hybrid approach, using polymers as the base
substrate and then modifying the surface with biomolecules.
For example, Synthemax (Corning), an acrylate polymer
modified with amino-containing peptides, has been shown to
be effective in the prolonged culture of multiple hESC lines
[20].
Of all the synthetic surfaces detailed thus far, only
PMEDSAH [22, 23] and APMAAm [21] have been reported
to maintain hPSCs for greater than 20 passages in defined and
xenogeneic-free culture medium. Because of the great number
of potential applications in regenerative medicine and tissue
engineering using hPSCs, it is desirable for culture substrates
to maintain numerous cell lines and cell types in an undiffer-
entiated state. To date, all the substrates detailed in this
review meet the criteria of having been used in the culture of
multiple hESC and hiPSC lines.
Biomedical products such as culture plates to expand
PSCs must be batch sterilized before use and thus it is impor-
tant for synthetic substrates to be compatible with common
sterilization techniques such as electron beam- and c-radia-
tion. However, substrates with biologic components such as
proteins and peptides do not readily lend themselves to com-
mon sterilization methods because the sterilization treatment
may denature or degrade the biologic moieties. At this time,
only Synthemax and PMEDSAH have shown compatibility
with common sterilization methods [20, 22, 38]. Furthermore,
the inclusion of peptides and proteins in stem cell culture sub-
strates may not allow the surfaces to be reused because bio-
molecules are known to undergo degradation from metallo-
proteinases secreted by cultured cells [39]. This observation
should also be considered as a factor for future clinical adop-
tion, as the inclusion of biomolecules leads to increased costs.
Due to the large number of stem cells that will likely be
needed for cell-based regenerative therapies [40], it will be
important to use processes to generate substrates that can be
scaled-up from the bench top to high-throughput manufactur-
ing processes. Modifying surfaces with peptides and proteins
can also hinder scale-up as it increases process complexity.
BIOLOGY OF SYNTHETIC SUBSTRATE-PSC
INTERACTIONS: MAINTENANCE OF SELF-
RENEWAL AND CONTROL OF DIFFERENTIATION
Several strategies have been used to develop synthetic sub-
strates for long-term hPSC culture. While the molecular
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mechanisms responsible for this support are not yet fully
characterized, the influence of material properties on cells is
currently an area of intense investigation. For substrates that
present cell adhesion elements such as heparin-binding pep-
tides [18] and laminin-derived peptides [12], the mechanism
of support for hPSCs may be due to these biological-mimick-
ing components. It is possible that substrates like PMVE-alt-
MA [17] and PMEDSAH [22], which contain carboxyl and
sulfonyl groups, mimic the functional characteristics of hepa-
rin, and in this way, support hPSCs. However, other material
properties, including hydrophilicity/hydrophobicity, surface
roughness, and stiffness of the culture substrate, can influence
hPSC behavior. For example, the wettability properties of
polymer coatings affect the adhesion of hPSCs. In this case,
hydrophobic materials are less permissive [22]. The roughness
of the substrate also impacts the fate of hPSCs. In terms of
adhesion, proliferation, and self-renewal, surfaces categorized
as smooth by a root-mean-square roughness (Rq) of 1 nm pro-
vide superior support to hESCs over nanorough surfaces with
an Rq = 75–150 nm [41]. Similarly, it has been shown that
rigid substrates maintain self-renewal of hESCs, while on soft
substrates stem cells are more prone to differentiate. These
data demonstrate that hESCs are mechanosensitive and
increase their cytoskeleton contractility with substrate rigidity
[42].
The chemical properties of the substrate also affect the
structural conformation of proteins that interact with the syn-
thetic coating. The source of the protein may be from factors
that are used to coat the surface, factors that are added to the
culture medium, and those factors that are secreted as stem
cells adhere to their physical environment in vitro [19]. For
example, the network structure of Matrigel and its ability to
support attachment and self-renewal of hESCs change
depending on the surface on which it is adsorbed [43]. In the
case of supplementary proteins, it has been shown that
APMAAm surfaces adsorb bovine serum albumin from the
culture medium in an unfolded state, allowing the prolifera-
tion of undifferentiated hESCs [21]. Taken together, these
examples illustrate the importance and complexity of the role
the microenvironment plays in self-renewal and differentiation
of hPSCs and suggests that synthetic substrates that support
hPSCs exhibit both chemical and mechanical properties that
support hPSC proliferation.
CULTURE OF PLURIPOTENT STEM CELLS IN
THREE-DIMENSIONAL BIOREACTORS
While the establishment of synthetic substrates and defined
culture conditions for hPSCs allows us to more precisely
probe the molecular basis of pluripotent stem cell self-renewal
and differentiation, the large-scale expansion of these cells for
future clinical use could be accelerated by the development of
three-dimensional cell-suspension cultures [40]. It is accepted
that hPSCs grow as adherent colonies and upon detachment
from supportive substrates, stem cells randomly differentiate
and the formation of embryoid bodies (EBs) is enabled. How-
ever, with the proper culture medium, undifferentiated hPSCs
can proliferate in suspension as spheroid clumps. Homoge-
nous populations of small cells with large nuclei can survive
and retain the expression of pluripotent stem cell markers and
the capability to differentiate in vivo and in vitro [44–47].
Interestingly, when hPSC spheroid clumps are cultured in sus-
pension with serum-containing medium, cystic EBs form and
evidence of differentiation is observed [44].
The long-term and large-scale propagation of both hESCs
and hiPSCs in bioreactors with serum-free medium and with-
out microcarriers in both static and dynamic cultures has been
reported [44–47]. Under these culture conditions, hPSCs have
been expanded for over 20 passages [44] and the proliferation
rates, although varying from study to study, have been
reported to be as high as 20-fold in 6 days, which is higher
than that reported for feeder cell cultures (approximately five-
fold) or feeder-free cultures (approximately ninefold) for the
same period of time [46]. It has been calculated that an initial
seeding density of 5  107 hPSCs per spinner flask would
result in a yield of at least 1.6  109 cells over five passages
[47].
DERIVATION AND LONG-TERM CULTURE OF
hPSCS on SYNTHETIC SUBSTRATES AND IN
CELL-SUSPENSION CULTURES: PHENOTYPIC,
GENETIC, AND EPIGENETIC STABILITY
As the field of regenerative medicine advances toward the de-
velopment of in vitro disease models from hPSC lines, both
directed genetic modification and derivation of new stem cell
lines need to be performed. This implies the successful expan-
sion of genetically modified single cells into an entire popula-
tion of hPSCs. Therefore, synthetic substrates should support
clonal growth of PSCs. To date, the proliferation of undiffer-
entiated single hPSCs has been reported on hit-9 surfaces
[19], while the derivation of new hiPSC lines on defined sub-
strates has been achieved on rh vitronectin [15] and in sus-
pension conditions with the addition of fibronectin, laminin,
and gelatin in the culture medium [45]. These newly derived
populations of hPSCs were shown to be phenotypically simi-
lar to cells derived on feeder cells. They expressed the char-
acteristic markers of PSCs, showed comparable cell-doubling
rates, and demonstrated the ability to differentiate into deriva-
tives of the three germ layers in vitro and in vivo. However,
equally important is the finding that derivation and long-term
culture of hPSCs on synthetic substrates and in bioreactors
may be accomplished without the introduction of genomic
abnormalities that may generate a selective advantage such as
a greater propensity for self-renewal [48]. Chromosomal
abnormalities have been reported in hPSCs after prolonged
culture as well as in early passages. These aberrations com-
monly involve nonrandom gains of chromosomes 12, 17, 20,
and X, or fragments of these chromosomes [49] as detected
by standard G-banding metaphase karyotype analysis. High-
resolution genome-wide analysis using array-based compara-
tive genomic hybridization techniques have shown recurrent
alterations in the same regions as well as others not detected
by standard karyotyping methods. One alteration frequently
reported is an amplification in the 20q11.21 region that
includes genes such as DNMT3B, ID1, HM13, and BCL2L1
[49, 50], which have been shown to be involved in cell prolif-
eration, inhibition of differentiation and apoptosis [51–53],
and may provide a strong selective advantage in culture com-
pared to normal cells. To date, all studies investigating the
expansion of hPSCs on synthetic substrates have reported nor-
mal karyotypes using the low-resolution G-banding technique.
However, for more rigorous interpretation of biological stud-
ies and a greater safety profile for eventual cell therapy, high-
resolution genome-wide studies should be performed.
The epigenetic stability of hPSCs is also important to con-
sider when using or developing new culture systems. The epi-
genetic status of genes can change dynamically with culture
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time and has been shown to be highly variable among differ-
ent hPSC lines and between sibling lines [49]. There have
been no systematic reports of potential epigenetic changes
when hPSC are cultured on synthetic substrates or in suspen-
sion. However, this will be an important consideration in light
of recent studies that related derivation and culture conditions
of female hiPSCs with erosion of DNA methylation and gene
expression on the inactive X chromosome. Such changes have
the potential to affect disease modeling, differentiation poten-
tial and clinical applications (see [54] for review).
FUTURE DIRECTIONS
The current knowledge of synthetic substrates and their char-
acteristics responsible for supporting the proliferation of un-
differentiated hPSCs will likely continue to evolve. A new
and deeper understanding of how chemical moieties support
or direct biologic behavior will lead to improvement in, and
development of, new synthetic substrates and will improve
our understanding of the biology of pluripotent stem cells.
Using the tuning capacity in chemical synthesis of polymer
substrates, it will be possible to investigate the response of
hPSCs to custom tailored chemical and mechanical signals to
maintain self-renewal or to perhaps induce cell-lineage-spe-
cific differentiation. Initial examples of this potential have
been demonstrated with mesenchymal stem cells, where ma-
trix elasticity of the culture substrate contributed to lineage
progression toward neurons, myoblasts, and osteoblasts [55].
One can envision that in combination with high-throughput
screenings, the use of small molecules, gene-transfection
libraries, and directed chemical manipulations, that synthetic
substrates will facilitate the development of defined culture
conditions for multiple cell-lineage commitment of hPSCs. In
this regard, the impact that synthetic substrates and chemi-
cally defined, xenogeneic-free medium for the culture of
hPSCs is already high and research in this area will continue
to play a prominent role in the development of strategies to
use hPSCs to treat debilitating human diseases.
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